A new injectable gel has shown promise in repairing pelvic floor damage caused by childbirth, according to a recent study conducted on rats and human tissue. Pelvic floor disorders, which can occur as a result of injuries associated with vaginal childbirth, have limited treatment options. Current treatment options include exercises and surgery, but these do not directly address the scarring or wasting of the pelvic floor muscles. The new gel, however, has the potential to repair and heal these muscles.

The pelvic floor is a hammock of muscle and connective tissue that supports the pelvic and abdominal organs. It helps prevent incontinence and makes sex more pleasurable by supporting and contracting the organs. Pelvic floor disorders, including pelvic organ prolapse (POP), affect 25% of women in the US and are often caused by muscle damage during childbirth. However, scientists are still unsure of the exact cause of muscle malfunction.

The study compared tissue samples from women with POP to samples from organ donors who had never had the disorder. The samples from women with POP showed thinner and scarred pelvic floor muscles. Similar changes were observed in rats with simulated pelvic floor injuries. However, these changes reversed after treatment with the gel, which promoted muscle repair and healing.

The gel is made from the extracellular matrix of muscle tissue taken from pigs. This matrix is the physical framework that supports cells. After removing the cells and testing for contaminants, the matrix is ground into a powder and mixed with sterile salt water. The resulting gel is injected into the damaged muscle, where it solidifies and resembles the structure of normal muscle tissue. As the gel breaks down, it releases substances that attract immune cells to aid in tissue repair.

The gel has several advantages as a treatment option. It is cost-effective, can be delivered through injection, and does not require special storage conditions. Future studies will focus on evaluating the function of pelvic floor muscles and the changes in gene expression that occur during muscle damage and gel injection. Although the gel has only been tested in rats, further studies are needed to test its safety and efficacy in humans.

Overall, while more research is necessary, the initial findings of the study are promising. The gel has the potential for clinical translation and could provide a new and effective treatment option for pelvic floor disorders caused by childbirth.